Orthofix Medical Inc. (OFIX) 8-K Current Report: February 24, 2026
Filed: February 24, 2026
Health Care
Surgical & Medical Instruments & ApparatusOrthofix Medical Inc. (OFIX) 8-K current report filed with SEC EDGAR on February 24, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 2.02: Results of Operations and Financial Condition
- Item 7.01: Regulation FD Disclosure
Orthofix Medical Inc. 8-K Feb 24, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Item 2.02 covers OFIX earnings disclosure; actual results (revenue, EPS, EBITDA figures) are in the accompanying press release exhibit, not this section
- • Non-GAAP framework excludes share-based comp, SeaSpine merger integration costs, M6 disc product line restructuring/impairments, and acquired intangible amortization
- • Long-term normalized tax rate set at 28% for 2024–2025 adjusted results — actual GAAP tax may diverge materially
- • Adjusted EBITDA is primary metric used by chief operating decision maker — most relevant figure for management performance evaluation and peer comparison
- • SeaSpine merger (closed Jan 2023) and M6 disc discontinuation remain active non-GAAP exclusion items — signals ongoing integration/restructuring drag on GAAP earnings
Item 7.01 · Regulation FD Disclosure
- • Updated investor presentation (Exhibit 99.2) to be used in analyst/investor meetings throughout fiscal year 2025
- • Presentation may be modified over time — signals management actively refining its equity story for current market conditions
- • Key substance in Exhibit 99.2; investors should review that document directly for strategic priorities and financial targets
Get deeper insights on Orthofix Medical Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.